Status | Study |
Completed |
Study Name: Evaluation of Boostrix™10 Years After Previous Booster Vaccination Condition: Acellular Pertussis Tetanus Diphtheria Date: 2010-05-20 Interventions: Biological: Boostrix™ In |
Completed |
Study Name: Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children Condition: Haemophilus Influenzae Type b (Hib) Infection Date: 2010-05-14 Interventions: Biological: Monovalent glyco-conjugated vaccine against Haemophilus influenz |
Completed |
Study Name: Post Market Surveillance for Infanrix™ Condition: Diphtheria Acellular Pertussis Tetanus Date: 2009-05-21 Interventions: Biological: GSK Biologicals' Infanrix™ Primary and booster vaccination according to vaccination sc |
Completed |
Study Name: Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years Condition: Tetanus Acellular Pertussis Diphtheria Date: 2009-03-26 Interventions: Biological: GSK Biologicals'Kinrix® |
Completed |
Study Name: Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine. Condition: Tetanus Acellular Pertussis Diphtheria Date: 2009-02-02 Interventions: Biological: Boostrix® Int |
Completed |
Study Name: Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children Condition: Acellular Pertussis Diphtheria Tetanus Date: 2008-06-05 Interventions: Biological: Infanrix™ In |
Completed |
Study Name: Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination Condition: Acellular Pertussis Tetanus Diphtheria Date: 2007-10-22 Interventions: Biological: Boostrix™ Intramuscular injection, 1 dose |
Terminated |
Study Name: Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. Condition: Acellular Pertussis Tetanus Diphtheria Date: 2007-10-15 Interventions: Biological: INFANRIX Biological: BOOSTRIX |
Completed |
Study Name: Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 Condition: Acellular Pertussis Tetanus Diphtheria Date: 2007-06-21 Interventions: Procedure: Taking of blood samples |
Completed |
Study Name: Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine Condition: Diphtheria Acellular Pertussis Tetanus Date: 2007-03-26 Interventions: Biological: Boostrix Biological: Chinese D |